I. Introduction S100 proteins constitute a large family of small (10-14 kDa) Ca 2+ -binding proteins characterized by two EFhands as Ca 2+ -binding sites, and exhibit a variety of functions, including cell growth and differentiation, cytoskeletal dynamics, and Ca 2+ homeostasis (for a review see [12] ). Originally, S100α and S100β were isolated in the bovine brain [28] and in the past decade, approximately twenty S100 genes have been identified in a variety of species, including humans and mice [23] . S100 proteins exist as homo or hetero dimers in solution, and upon Ca 2+ -binding, they undergo a large conformational change, which enables these proteins to interact with various target proteins. Through these interactions, S100 proteins transduce environmental signals for intracellular activities such as cAMP mediated-signaling and vesicular transportation/exocytosis (for a review see [7] ). In addition, some S100 proteins (e.g. S100B and S100A12) are secreted from cells, and bind to cell-surface receptors such as the receptor of advanced glycation endproducts (RAGE), and produce extracellular effects on neurons and inflammatory cells [3, 10, 31] . S100 proteins have also attracted much interest owing to their close association with a number of human diseases, including cancer, chronic inflammation, neurodegenerative disorders and cardiomyopathies, which suggests the potency of S100 proteins as diagnostic marker and therapeutic drug targets, although the precise mechanisms by which S100 proteins participate in disease occurrence remain largely unknown (for a review see [13] ). Several lines of evidence have demonstrated S100 protein-like immunoreactivity [26, 29] and S100-gene expression by microarray analysis in the ovarian tumor [6, 14, 18] . However, little is known about the subtype-specific immunological distribution pattern of S100 proteins, particularly in the normal reproductive tissue, with the exceptions of S100A10 and S100A11 [11] .
Therefore, immunohistochemical analysis of S100 proteins other than S100A10 and S100A11 in the normal reproductive tissue is certainly essential for understanding the biology of S100 proteins. S100A6 (formerly named calcyclin) was first identified as a gene, the expression level of which increased when quiescent cells were stimulated to proliferate [15] . Its involvement in the process of cell cycle has been validated by several lines of evidence demonstrating reduced proliferative activities in S100A6 gene-deficient cells [4, 16, 20, 30] . S100A6 interacts with many targets, including Siah-1-interacting protein (SIP), glyceraldehydes-3-phosphatase dehydrogenase (GAPDH) and several annexins (for a review see [21] ). S100A6 expression is elevated in a number of malignant tumors, such as acute myeloid leukemia, neuroblastoma and melanoma cell lines [5, 35] ; therefore S100A6 may be a useful diagnostic marker for defining cancer stage. However, the precise molecular mechanism by which S100A6 regulates tumorigenesis remains unknown.
In the present study, we investigated the distribution of S100A6 in the normal murine ovary and found that S100A6 is expressed prominently in the luteal cells of the CL and that S100A6 expression positively correlated with the expression of a steroidogenic enzyme. In addition, S100A6 was also colocalized with S100A11, another S100 protein, in the luteal cells, which implies that two S100 proteins have some combined effect on the steroidogenic activity of luteal cells.
II. Materials and Methods

Animals
ICR female mice (10-12 weeks old) were obtained from the CLEA Japan (Tokyo, Japan). All mouse experiments were approved of and performed in accordance with the guidelines of the Animal Care Committee of Toho University.
Cloning and bacterial expression of mouse S100A6
Total RNA was isolated from the mouse ovary using RNA Bee (AMS Biotech., Abingdon, UK). RT-PCR was performed with ~5 μg of cDNA templates reversetranscribed from the mouse ovary RNA. Oligonucleotide PCR primers were synthesized on the basis of the corresponding N-and C-terminal sequences of mouse S100A6 (5'-CATATGCATGCCCTCTGG-3' and 5'-CGGATCCTTA TTTCAGAGCT-3' for N-and C-termini respectively). The initiation and stop codons are underlined. Amplification was performed as follows: 10 sec at 98°C, 15 sec at 61°C, and 90 sec at 68°C for 35 cycles. PCR products were subcloned into pGEM-T (Promega, Madison, WI), and found to be identical to the coding regions of S100A6 protein. The NdeI-and SpeI-digested fragment was excised and ligated with pET3a (Novagen, EMD, Darmstadt, Germany). For protein expression, the recombinant plasmid was introduced into Escherichia coli BL21 pLysS (Novagen). After induction of expression by IPTG, recombinant S100A6 was purified according to the method for the purification of frog S100-like calcium binding protein described previously [27] .
Western blot analysis of S100 proteins
Known amounts (50, 150 and 300 pmoles) of recombinant S100 proteins (S100A6 and S100A11) were electrophoresed in 15-20% precast gradient gel (WAKO, Osaka, Japan) and transferred onto a PVDF membrane (Immobilon P; Millipore, Bedford, MA). After blocking, blots were probed with the primary antibodies (sheep polyclonal anti-S100A6 antibody, 1:100, R&D systems, Mineapolis, MN; sheep polyclonal anti-S100A11 antibody, 1:100, Randox Life Science, Crumlin, UK). After washing, blots were reacted with HRP-conjugated secondary antibody (MP Biomedicals, Aurora, OH), and immunoreactive proteins were acquired using LAS-1000 (Fuji Film, Tokyo, Japan).
Immunohistochemistry
Ovaries were dissected from mice with normal estrous cycle, and fixed in 10% formalin, dehydrated with alcohol, embedded in paraffin, and cut at ~5 μm thickness. After blocking, the specimens were subjected to a standard immunohistochemical procedure using commercially available antibodies (sheep or rat polyclonal anti-S100A6 antibody, 1:100; sheep polyclonal anti-S100A11 antibody, 1:100; rabbit polyclonal anti-cytochrome P450 11A (CYP11A) antibody, 1:100, ProteinTech, Chicago, IL). After rinse, the specimens were treated with secondary antibodies (Alexa Fluor 594 and Alexa Fluor 488; 1:1000, Molecular Probes, Invitrogen, Carlsbad, CA) and nuclei-stained by DAPI (1 μg/ml; Dojindo, Kumamoto, Japan). Negative controls were performed by substituting the primary antibody with a non-immune normal IgG from the same sources at the same concentration. Stained specimens were observed using either a conventional fluorescence microscope (Olympus, Tokyo, Japan) or an inverted confocal laser microscope (LSM510; Carl Zeiss, Oberkochen, Germany) with an appropriate set of excitation and emission filters.
Quantitative evaluation
For quantitative analyses with a confocal microscope, the aperture, detector gain, and offset were kept constant during a series of observations, and signal intensity was set within a linear range (8 bit scale, 0-255). Images were captured at the optical slice of <0.6 μm, and quantified areas (10 μm 2 each, 180 pixels) were randomly chosen. To quantitatively evaluate the colocalization of S100A6 with CYP11A, the mean intensity of the cytoplasm of luteal cells within the defined area (10 μm 2 each) was quantified by using a software attached to the confocal laser microscope, and subtracted by the mean intensity in follicle cell as a background control, followed by the regression analysis as described elsewhere [1, 24] . Statistical significance was tested by analysis of variance (ANOVA). All quantifications were performed with lab personnel blinded to the conditions.
III. Results and Discussion
Specificity of antibodies
In general, amino acid-sequence homologies of mouse S100 proteins are not necessarily high, and occur within a range of 10-56% homology. In particular, sequence homology between S100A6 and S100A11 is substantially low (~20%). Since questions may be raised as to the antibodyspecificity among subtypes of one large protein family, we cloned mouse S100A6 from the murine ovary cDNA and examined the specificity of antibodies by Western analysis using recombinant S100A6 and recombinant S100A11, another S100 protein that was subsequently focused on in this study. Anti-S100A6 antibody exhibited immunoreactivity against recombinant S100A6 but showed no crossreaction even against excessive amount of S100A11 (6-fold quantity of S100A6) (Fig. 1A) . Meanwhile, anti-S100A11 antibody reacted with recombinant S100A11, but not with the excessive amounts of S100A6 (Fig. 1B) . These results essentially confirmed the specificity of the two antibodies.
Localization of S100A6 in the murine ovary
We examined the distribution pattern of S100A6 in the murine ovary by immunohistochemistry using the specific antibody described above. The result showed that S100A6 is localized substantially in the corpus luteum (CL in Fig. 2A , Left) but not in the follicle (F in Fig. 2A) . Interestingly, S100A6+ CLs showed a varied staining appearance: all luteal cells were immunopositive in some CLs ( Fig. 2A , CL demarcated by a broken line), whereas a limited number of luteal cells was immunopositive in other CLs ( Fig. 2A , CL demarcated by a solid line). Furthermore, although S100A6 was present in the cytoplasm of luteal cells in both types of CLs (Fig. 2B) , the intensity of S100A6-staining displayed considerable variation between the two types of CLs. The staining intensity was comparatively homogeneous in the former type of CL (referred to as homo CL), whereas it was heterogeneous in the latter type of CLs (referred to as hetero CL) (see Fig. 2B , Left; intense signal (arrow) and weak one (arrowhead)). This heterogeneous staining pattern implies that the S100A6 expression level may represent meaningful differences in the maturation process of luteal cells. Incidentally, in the hetero CL, we observed much autofluorescence (asterisk; Fig. 2B , Left), possibly due to residual red blood cells, which suggested that the hetero CL was well vasculated and therefore represented differentiating CL at the early luteal stage [2] . Meanwhile, the homo CLs contained sinusoidal-like structure (arrowheads; Fig. 2B , Right), suggesting that these CLs were matured CLs at the mid luteal stage [2] . It should be noted that the existence of two CLs at different developmental stages in the identical ovary is due to the short estrous cycle in mice, which is consistent with another report [34] .
Colocalization of S100A6 with a steroidogenic enzyme in the luteal cells Several steroidogenic enzymes have been reported to alter their amounts during the developmental stages of the mammalian CL. For example, cytochrome P450 11A (CYP11A), a first and rate-limiting enzyme that cleaves the side chain of cholesterol producing pregnenolon, increases in the number of immunopositive cells as the CL differentiates [33] . To characterize the nature of S100A6+ luteal cells, we examined the colocalization of S100A6 with CYP11A. The result showed that S100A6 colocalized with CYP11A both in the hetero (Fig. 3A ) and homo CLs (not shown). To investigate the potential correlation between expression levels of S100A6 and CYP11A, we quantified the mean intensity of S100A6-and CYP11A-immunopositive cytosolic regions within a small defined area (10 μm 2 ) in the hetero CLs, and performed regression analysis. The result clearly demonstrated a positive correlation between the expression levels of these two proteins ( Fig. 3B ; n=100, three mice, F(1,32)=30, p<0.01, ANOVA): S100A6 expression level was increased in parallel with CYP11A expression level, which suggested that S100A6 expression may be involved in an increase in the steroidogenic activity of luteal cells. CYP gene expression has been shown to be regulated by ubiquitous transcription factors such as AP-1 and SP-1, but more efficiently by ovary-specific transcription factors such as steroidogenic factor-1 (SF-1) and LRH-1 [8, 22] . Our computational analysis to estimate the transcription binding site in the S100A6 gene surely found both the AP-1 and SP-1 sites but unfortunately failed to detect the sites for SF-1 or LRH-1 (not shown), suggesting that the transcriptional regulation of S100A6 gene may be different from that of CYP11A.
Colocalization of S100A6 with S100A11 in luteal cells
Since we recently discovered that S100A11, another Top: CBB-stained pattern of recombinant S100A11 (50 pmoles), and recombinant S100A6 (50, 150 and 300 pmoles), Bottom: treated with anti-S100A11 antibody. S100 protein, was localized in the cytoplasm in the luteal cells [11] similarly as seen for S100A6 in our current study, we next examined colocalization of these two S100 proteins. The result revealed that S100A6 and S100A11 colocalized in luteal cells in the hetero CL (Fig. 4) , which indicated that these two proteins are concomitantly expressed in the luteal cells during luteal cell development. CL is formed via diverse cellular events involving the attenuation of cell proliferation and subsequent cell differentiation. The cyclin-dependent kinase (Cdk) inhibitor p21, the expression level of which is inhibited by β-catenin signaling, has been shown to cause cell cycle arrest, thereby initiating differentiation of luteal cells [17, 19] . S100A6 has been shown to interact with SIP, a Siah-1-interacting protein, which facilitates β-catenin degradation via ubiquitinylation in HEK293 cells, leading to p21 liberation [9, 25] . Interestingly, S100A11 has been shown to be phosphorylated in response to either exposure of high extracellular Ca 2+ or TGFβ, which leads to p21 expression, induces growth inhibition of human keratinocytes. Thus, S100A6 and S100A11 may interact with individual targets, activating separate signaling pathways, and ultimately have a synergistic effect on the differentiation of luteal cells by enhancing p21 function. Furthermore, it is worth noting that the differentiation of luteal cells initially occurs at the stage of granulosa cells in the preovulatory follicle, following termination of the cell division by the LH surge (for a review see [32] ). Our immunohistochemical studies thus far have revealed no significant immunoreactivity against S100A6 ( Fig. 2A) or S100A11 [11] in granulosa cells in the preovulatory follicle, suggesting that S100A6 and S100A11 may be involved with the differentiation of luteal cells, particularly after ovulation in the CL.
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